Publicacións en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (1)

2021

  1. Minimal residual disease in Myeloma: Application for clinical care and new drug registration

    Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212